The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk

Vitamin D deficiency and myocardial structure and function in older men and women: The Hoorn Study

(2014) Stefan Pilz et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

(2013) Chad D. Touchberry et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

(2013) Benjamin D. Parker   ANNALS OF INTERNAL MEDICINE

FGF23 Modifies the Relationship Between Vitamin D and Cardiac Remodeling

(2013) Bonnie Ky et al.   Circulation-Heart Failure

Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation

(2013) L. C. Baia et al.   Clinical Journal of the American Society of Nephrology

Vitamin D and cardiovascular disease: is the evidence solid?

(2013) I. Al Mheid et al.   EUROPEAN HEART JOURNAL

Serum 25-hydroxyvitamin D and left ventricular systolic function in a non-smoking population: the Tromsø Study

(2013) Elena Kamycheva et al.   EUROPEAN JOURNAL OF HEART FAILURE

Racial Differences in the Association of Serum 25-Hydroxyvitamin D Concentration With Coronary Heart Disease Events

(2013) Cassianne Robinson-Cohen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia

(2013) Harlan M. Krumholz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum Vitamin D and Parathyroid Hormone in Relation to Cardiac Structure and Function: The ICELAND-MI Substudy of AGES-Reykjavik

(2013) A. J. van Ballegooijen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals

(2013) S. Masson et al.   JOURNAL OF INTERNAL MEDICINE

Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging

(2013) P. Ameri et al.   JOURNAL OF INTERNAL MEDICINE

Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: a nested case-control study in Italy

(2013) Ursula Kirchmayer et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)

(2013) Per-Anton Westerberg et al.   BMC Nephrology

Thirty-day complications after laparoscopic or open cholecystectomy: a population-based cohort study in Italy

(2013) Nera Agabiti et al.   BMJ Open

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

(2013) C. R. Dormuth et al.   BMJ-British Medical Journal

Relation of Vitamin D and Parathyroid Hormone to Cardiac Biomarkers and to Left Ventricular Mass (from the Cardiovascular Health Study)

(2012) Adriana J. van Ballegooijen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD

(2012) Kelsey Smith et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Vitamin D in Relation to Myocardial Structure and Function after Eight Years of Follow-Up: The Hoorn Study

(2012) A.J. van Ballegooijen et al.   ANNALS OF NUTRITION AND METABOLISM

25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death

(2012) Peter Brøndum-Jacobsen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease

(2012) Lu Wang et al.  

Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

(2012) Christian Murr et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Calcium and phosphate impact cardiovascular risk

(2012) Gunnar H. Heine et al.   EUROPEAN HEART JOURNAL

Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12 000 deaths

(2012) Joseph Tomson et al.   EUROPEAN HEART JOURNAL

Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy

(2012) Gian Francesco Mureddu et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reporting of Quality Indicators and Improvement in Hospital Performance: The P.Re.Val.E. Regional Outcome Evaluation Program

(2012) Cristina Renzi et al.   HEALTH SERVICES RESEARCH

Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes

(2012) Gregory P. Levin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ASSOCIATION OF FIBROBLAST GROWTH FACTOR (FGF)-23 LEVELS WITH RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

(2012) Jacob A. Udell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

(2012) Joachim H. Ix et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community

(2012) Johan Ärnlöv et al.   KIDNEY INTERNATIONAL

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

(2012) Damien Gruson et al.   PEPTIDES

Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy

(2011) Songcang Chen et al.   CIRCULATION

FGF23: Is It Ready for Prime Time?

(2011) K. Wesseling-Perry   CLINICAL CHEMISTRY

Fibroblast Growth Factor 23, Cardiovascular Disease Risk Factors, and Phosphorus Intake in the Health Professionals Follow-up Study

(2011) O. M. Gutierrez et al.   Clinical Journal of the American Society of Nephrology

The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation

(2011) Sarah Seiler et al.   EUROPEAN HEART JOURNAL

Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure

(2011) Max Plischke et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk Prediction Models for Hospital Readmission

(2011) Devan Kansagara et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Confounding Control in Healthcare Database Research

(2010) M. Alan Brookhart et al.   MEDICAL CARE

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

(2010) A. Kirkpantur et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults

(2009) R D Semba et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Socioeconomic Differences in Stroke Incidence and Prognosis Under a Universal Healthcare System

(2009) Giulia Cesaroni et al.   STROKE